| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |